血脑障壁给药市场：2023年至2030年给药技术、基于用途的全球预测

预计到 2023 年，全球血脑屏障给药市场将达到 6.6715 亿美元，年复合成长率为 9.04%，预计到 2030 年将增长至惊人的 12.2438 亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球血脑屏障给药市场至关重要。透过检验业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.跨越血脑障壁的药物输送的全球市场规模和预测是多少？

2.在预测期内，COVID-19对全球血脑障壁跨越药物输送市场的阻碍因素与影响有哪些？

3.在预测期内，全球血脑障壁药物输送市场需要投资哪些产品/细分市场/用途/领域？

4. 全球跨血脑障壁给药市场的竞争策略为何？

5.全球跨血脑屏障给药市场的技术趋势和法律规范是什么？

6.全球血脑障壁给药市场主要厂商的市占率为何？

7. 哪些型态和策略性措施被认为适合进入跨血脑障壁药物输送的全球市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

• 市场动态
  • 促进因素
    • 阿兹海默症等神经系统疾病的发生率增加
    • 失智症盛行率上升，主要影响老年人口
    • 长期照护患者的医疗费用增加
  • 抑制因素
    • 血脑屏障（BBB）有效限制治疗药物渗入大脑
  • 机会
    • 增加奈米技术在治疗各种医疗状况的应用
    • 不断发展的医疗旅游业和长期照护设施
    • 加大医药研发投入
  • 任务
    • 与治疗药物相关的严重副作用
• 市场趋势
• COVID-19 的累积影响
• 俄罗斯-乌克兰衝突的累积影响
• 高通膨的累积效应
• 波特五力分析
• 价值炼和关键路径分析
• 法律规范
• 客户客製化

第6章跨越血脑障壁的药物输送市场：依药物输送技术分类

• 介绍
• 双特异性抗体 RMT 方法
• 被动扩散
• 改善 BBB渗透性
• 特洛伊木马的方法

第7章跨越血脑障壁的药物输送市场：用途

• 介绍
• 阿兹海默氏症
• 脑肿瘤
• 癫痫
• 猎人症候群
• 多发性硬化症
• 帕金森氏症

第8章北美和南美跨血脑屏障给药市场

• 介绍
• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第9章亚太血脑障壁药物输送市场

• 介绍
• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第10章欧洲、中东和非洲的血脑屏障给药市场

• 介绍
• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第11章竞争形势

• FPNV定位矩阵
• 市占率分析：主要企业
• 竞争情境分析：主要企业

第12章上市公司名单

第13章附录

• 讨论指南
• 关于许可证和定价

The Global Drug Delivery Across Blood Brain Barrier Market is forecasted to grow significantly, with a projected USD 667.15 million in 2023 at a CAGR of 9.04% and expected to reach a staggering USD 1,224.38 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Drug Delivery Across Blood Brain Barrier Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Drug Delivery Across Blood Brain Barrier Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Drug Delivery Technology, market is studied across Bispecific Antibody RMT Approach, Passive Diffusion, Permeability Increase of BBB, and Trojan Horse Approach. The Bispecific Antibody RMT Approach is projected to witness significant market share during forecast period.

Based on Application, market is studied across Alzheimer's Disease, Brain Cancer, Epilepsy, Hunter's Syndrome, Multiple Sclerosis, and Parkinson's Disease. The Alzheimer's Disease is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Drug Delivery Across Blood Brain Barrier Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Drug Delivery Across Blood Brain Barrier Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Drug Delivery Across Blood Brain Barrier Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Drug Delivery Across Blood Brain Barrier Market?

4. What is the competitive strategic window for opportunities in the Global Drug Delivery Across Blood Brain Barrier Market?

5. What are the technology trends and regulatory frameworks in the Global Drug Delivery Across Blood Brain Barrier Market?

6. What is the market share of the leading vendors in the Global Drug Delivery Across Blood Brain Barrier Market?

7. What modes and strategic moves are considered suitable for entering the Global Drug Delivery Across Blood Brain Barrier Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Drug Delivery Across Blood Brain Barrier Market, by Drug Delivery Technology, 2022 vs 2030
• 4.3. Drug Delivery Across Blood Brain Barrier Market, by Application, 2022 vs 2030
• 4.4. Drug Delivery Across Blood Brain Barrier Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidences of neurological disorders, such as Alzheimer's disease
    • 5.1.1.2. Rising prevalence of dementia, majorly affecting the elderly population
    • 5.1.1.3. Rising healthcare expenditure for long term care patients
  • 5.1.2. Restraints
    • 5.1.2.1. Blood-brain barrier (BBB) efficiently restricts penetration of therapeutic agents to the brain
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing the use of nanotechnology in treating various medical conditions
    • 5.1.3.2. Growing medical tourism industry and long-term care facilities
    • 5.1.3.3. Growing investment in pharmaceutical research & development
  • 5.1.4. Challenges
    • 5.1.4.1. Serious side effects associated with therapeutic drugs
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Drug Delivery Across Blood Brain Barrier Market, by Drug Delivery Technology

• 6.1. Introduction
• 6.2. Bispecific Antibody RMT Approach
• 6.3. Passive Diffusion
• 6.4. Permeability Increase of BBB
• 6.5. Trojan Horse Approach

7. Drug Delivery Across Blood Brain Barrier Market, by Application

• 7.1. Introduction
• 7.2. Alzheimer's Disease
• 7.3. Brain Cancer
• 7.4. Epilepsy
• 7.5. Hunter's Syndrome
• 7.6. Multiple Sclerosis
• 7.7. Parkinson's Disease

8. Americas Drug Delivery Across Blood Brain Barrier Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Drug Delivery Across Blood Brain Barrier Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Drug Delivery Across Blood Brain Barrier Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET RESEARCH PROCESS
• FIGURE 2. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, 2022 VS 2030
• FIGURE 3. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2022 VS 2030 (%)
• FIGURE 5. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 6. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 7. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET DYNAMICS
• FIGURE 8. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. UNITED STATES DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. ASIA-PACIFIC DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 15. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 5. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY BISPECIFIC ANTIBODY RMT APPROACH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY PASSIVE DIFFUSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY PERMEABILITY INCREASE OF BBB, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY TROJAN HORSE APPROACH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 10. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY BRAIN CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY HUNTER'S SYNDROME, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 22. BRAZIL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. CANADA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 24. CANADA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 26. MEXICO DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 34. AUSTRALIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. CHINA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 36. CHINA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. INDIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 38. INDIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. INDONESIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 42. JAPAN DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. MALAYSIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 46. PHILIPPINES DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. SINGAPORE DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. SOUTH KOREA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 52. TAIWAN DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. THAILAND DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 56. VIETNAM DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. DENMARK DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 63. EGYPT DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. FINLAND DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 67. FRANCE DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. GERMANY DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 71. ISRAEL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. ITALY DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 73. ITALY DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. NETHERLANDS DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 77. NIGERIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 79. NORWAY DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. POLAND DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. POLAND DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. QATAR DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 83. QATAR DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 85. RUSSIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 87. SAUDI ARABIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH AFRICA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. SPAIN DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 93. SWEDEN DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 95. SWITZERLAND DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. TURKEY DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 99. UNITED ARAB EMIRATES DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 101. UNITED KINGDOM DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 103. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 104. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET LICENSE & PRICING